Abstract:Salidroside (SAL) is a phenylpropanoid glycoside isolated from the medicinal plant Rhodiola rosea. A recent study has reported that SAL can efficiently decrease atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice. This study was to investigate the molecular mechanism of antiatherogenic effects of SAL. Given the importance of endothelial nitric oxide synthase (eNOS) in atherosclerosis, we sought to elucidate whether SAL could stimulate eNOS activation and also to explore its upstream signaling pathway. Six-week old apoE−/− male mice were fed a high-fat diet for 8weeks and then were administered with SAL for another 8weeks. SAL significantly improved endothelial function associated with increasing eNOS activation, thus reduced the atherosclerotic lesion area. SAL increased eNOS-Ser1177 phosphorylation and decreased eNOS-Thr495 phosphorylation, indicative of eNOS activation in endothelium. The aortic sinus lesions in SAL treated mice displayed reduced inflammation. SAL significantly activated AMP-activated protein kinase (AMPK). Both AMPK inhibitor and AMPK small interfering RNA (siRNA) abolished SAL-induced Akt-Ser473 and eNOS-Ser1177 phosphorylation. In contrast, LY294002, the PI3k/Akt pathway inhibitor, abolished SAL-induced phosphorylation and expression of eNOS. High performance liquid chromatography (HPLC) analysis revealed that SAL decreased cellular ATP content and increased the cellular AMP/ATP ratio, which was associated with the activation of AMPK. SAL was found to decrease the mitochondrial membrane potential (ΔΨm), which is a likely consequence of reduced ATP production. The action of SAL to reduce atherosclerotic lesion formation may at least be attributed to its effect on improving endothelial function by promoting nitric oxide (NO) production, which was associated with mitochondrial depolarization and subsequent activation of the AMPK/PI3K/Akt/eNOS pathway. Taken together, our data described the effects of SAL on mitochondria, which played critical roles in improving endothelial function in atherosclerosis.

Salidroside - Can it be a Multifunctional Drug?

A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines

Salidroside Induces Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells

Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties

Salidroside: An Overview of Its Promising Potential and Diverse Applications

The Sources of Salidroside and Its Targeting for Multiple Chronic Diseases

Pharmacological functions of salidroside in renal diseases: facts and perspectives

The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated Review

Pharmacological Activities and Progress in Structure Modification of Salidroside

Salidroside: A Promising Agent in Bone Metabolism Modulation

Rhodiola and Salidroside in the Treatment of Metabolic Disorders

Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases

Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase.

Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway

Biosynthesis and biotechnological production of salidroside from Rhodiola genus plants

Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins

Progress on the Role of Salidroside in Neurodegenerative Diseases

Chemical Synthesis, Experimental, Molecular Docking and Drug-likeness Studies of Salidroside

Salidroside, A Natural Antioxidant, Improves Β-Cell Survival and Function Via Activating AMPK Pathway

Immunmodulatory and Antiproliferative Properties of Rhodiola Species

Salidroside inhibits the growth of human breast cancer in vitro and in vivo.